Editorial: a painful prospect-with no analgesic.
Explore the source record for details and available documents.
Economics↗
Biomedical subjects
E G Feldmann
Publications and source records attributed to E G Feldmann.
Editorial: The value of congressional oversight.
Explore the source record for details and available documents.
United States↗
Editorial: The fifth freedom: scientific communication.
Explore the source record for details and available documents.
Communication↗
Editorial: National research policy.
Explore the source record for details and available documents.
Legislation as Topic↗
Future of drug compendia.
Explore the source record for details and available documents.
Formularies as Topic↗
Traditional function of pharmacy.
Explore the source record for details and available documents.
Chemistry, Pharmaceutical↗
Editorial: Harmless, but ineffective, remedies.
Explore the source record for details and available documents.
Amygdalin↗
Editorial: Bioavailability data--useful or useless?
Explore the source record for details and available documents.
Biological Availability↗
Letter: Digoxin tablets dissolution test.
Explore the source record for details and available documents.
Digoxin↗
Editorial: Achieving the full viewpoint.
Explore the source record for details and available documents.
Peer Review↗
On being our brother's keeper.
Explore the source record for details and available documents.
Drug Industry↗
Editorial: Extremism in the pursuit of drug abuse prevention.
Explore the source record for details and available documents.
Humans↗
Drug information and drug performance. The need for standardization and uniformity.
Explore the source record for details and available documents.
Drug Labeling↗
Editorial: Open system in name only?
Explore the source record for details and available documents.
Drug Industry↗
Editorial: Drugs anonymous?
Explore the source record for details and available documents.
California↗
Editorial: Destructive fallout.
Explore the source record for details and available documents.
Drug Industry↗
Editorial: Advice, not advocacy.
Explore the source record for details and available documents.
Biopharmaceutics↗
Editorial: Dr. Jekyll and Mr. Hyde.
Explore the source record for details and available documents.
Humans↗